Author Correction: Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis.
Resource Type
Authors
Kim YT; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea.; Huh JW; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Choi YH; R&D Center, MirimGENE, Incheon, Republic of Korea.; Yoon HK; R&D Center, MirimGENE, Incheon, Republic of Korea.; Nguyen TT; R&D Center, MirimGENE, Incheon, Republic of Korea.; Chun E; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea.; Jeong G; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea.; Park S; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea.; Ahn S; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.; Lee WK; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea.; Noh YW; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea.; Lee KS; Non-Clinical Evaluation Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea.; Ahn HS; Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.; Lee C; Chemical & Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.; Lee SM; Department of Internal Medicine, Gil Medical Center, College of Medicine, Gachon University, Incheon, Republic of Korea.; Kim KS; Department of Emergency Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Suh GJ; Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Jeon K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Kim S; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, The interdisciplinary graduate program in integrative biotechnology, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Republic of Korea.; Jin M; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea. mirimj@gachon.ac.kr.; R&D Center, MirimGENE, Incheon, Republic of Korea. mirimj@gachon.ac.kr.; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea. mirimj@gachon.ac.kr.; Department of Microbiology, College of Medicine, Gachon University, Incheon, Republic of Korea. mirimj@gachon.ac.kr.
Source
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101487380 Publication Model: Print Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: PubMed not MEDLINE; MEDLINE